New imaging probes could spot prostate cancer missed by standard scans

NCT ID NCT07363382

First seen Jan 29, 2026 · Last updated May 14, 2026 · Updated 11 times

Summary

This study tests two new imaging probes (68Ga-G21 and 68Ga-G23) that target a protein found on most prostate cancer cells. The goal is to see if these probes can detect and stage prostate cancer better than current scans, especially when standard PSMA PET scans are negative or unclear. Six adults with prostate cancer will receive both the new and standard scans to compare their accuracy and safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University

    RECRUITING

    Fuzhou, Fujian, 350005, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.